Paullone is a potent inhibitor of Cdk (cyclin-dependent kinases), which are involved in the regulation of the cell cycle.
1. Kamb, A., et al., 1998. Cyclin-dependent kinase inhibitors and human cancer. Current topics in microbiology and immunology. 227(): 139-48. PMID: 9479829
2. Schultz, C., et al., 1999. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. Journal of medicinal chemistry. 42(15): 2909-19. PMID: 10425100
3. Lahusen, Tyler., et al., 2003. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential. Molecular carcinogenesis. 36(4): 183-94. PMID: 12669310
4. Kunick, Conrad., et al., 2005. Structure-aided optimization of kinase inhibitors derived from alsterpaullone. Chembiochem : a European journal of chemical biology. 6(3): 541-9. PMID: 15696597
See how others have used Paullone (CAS 142273-18-5). Click on the entry to view the PubMed entry .
PMID: # 29046299 Lee, HW. et al. 2017. Am. J. Physiol. Renal Physiol. 7: ajprenal.00338.2017.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.